Assembly Biosciences, Inc.ASMBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-51.15M
Near historical average
Average (9y)
$-47.86M
Historical baseline
Range
High:$22.49M
Low:$-96.49M
CAGR
+11.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-51.15M | -327.4% |
| 2023 | $22.49M | +126.6% |
| 2022 | $-84.56M | +12.4% |
| 2021 | $-96.49M | -48.0% |
| 2020 | $-65.18M | +23.9% |
| 2019 | $-85.62M | -31.1% |
| 2018 | $-65.30M | -6659.2% |
| 2017 | $995517.00 | +102.8% |
| 2016 | $-35.03M | -86.8% |
| 2015 | $-18.76M | - |